Umbilical cord
blood banking is a relatively new procedure that has been gaining wide
acceptance over the past decade. Blood present in the umbilical cord and
placenta is a rich source of adult stem cells. In the past, it was discarded as
medical waste. But nowadays, after the child birth, the blood present in the
cord is drawn to the sterile collection bank and sent to banks for storage or
donation. Baby cord blood can be
used to treat more than 80 diseases including cancers, blood disorders and
immune deficiencies. Leukemia is one of the most common life-threatening
conditions that can be treated with the umbilical cord blood stem cells. Moreover, several clinical trials are
underway exploring the umbilical cord tissue benefits and therapeutic applications. Stem cell research scientists have higher hopes that cord tissue cells can be
used to treat the spinal cord injuries and heart damages in near future. So,
the expectant families have three options before them – they can throw away the
life-saving resource, donate it to a public bank or store it in a private bank.
Baby cord blood banking industry
has been evolving rapidly over the last decade. Why not check out the
milestones in stem cell research and
cord blood history? The world’s first umbilical cord blood transplantation
(UCBT) took place in France on October 1988. The patient was a five year old
boy named Mattew Farrow suffering with Fanconi Anemia (FA). This incredible
medical event was made possible through an international collaboration. Dr. Arleen
Auerbach, Dr. Hal Broxmeyer and Dr. Eliance Gluckman joined their hands to
perform the first umbilical cord blood transplantation at Hospital Saint-Louis
in Paris. Mattew Farrow received the donor stem cells from his newborn
baby sister. Since then, the field of cord blood research and banking have come
a long way and has the potential to revolutionise the field of stem cell
research.
No comments:
Post a Comment